The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transthyretin Stabilizer Market Research Report 2025
Synopsis
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
TTR stabilizers work by binding to and stabilizing the TTR protein, preventing it from misfolding and forming amyloid fibrils. By stabilizing the TTR protein, these medications aim to slow down or halt the progression of the disease and potentially alleviate symptoms.
The global Transthyretin Stabilizer market was valued at US$ 1480 million in 2023 and is anticipated to reach US$ 2372.8 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global transthyretin stabilizer market refers to the market for medications and compounds used in the treatment of transthyretin amyloidosis (ATTR) by stabilizing the transthyretin (TTR) protein. This market encompasses various drugs that have been developed or under development as TTR stabilizers.
Currently, there are several TTR stabilizers that have gained regulatory approval or are in advanced stages of clinical development. The market is primarily driven by the rising prevalence of ATTR, increasing awareness of the disease, and the need for effective treatment options.
One of the key drugs in the market is tafamidis, which is approved in several countries for the treatment of ATTR polyneuropathy. Tafamidis has shown to stabilize TTR and slow disease progression in clinical trials. Other drugs such as diflunisal, AG10, inotersen, and patisiran are also being investigated and have shown promising results in clinical studies.
The market is expected to witness significant growth as more research is conducted on the development of TTR stabilizers and as regulatory approvals are obtained for these drugs in different regions. Additionally, the ongoing efforts to increase disease awareness among healthcare professionals and patients are likely to contribute to the market growth.
Key players in the global transthyretin stabilizer market include pharmaceutical companies such as Pfizer Inc., Alnylam Pharmaceuticals, Inc., Eidos Therapeutics, and Ionis Pharmaceuticals Inc., among others. These companies invest in research and development activities to develop new TTR stabilizers and expand their product portfolios.
Geographically, North America and Europe are leading regions in the market, primarily due to the higher prevalence of ATTR and the presence of established healthcare infrastructure. However, as awareness and diagnosis of ATTR improve in other regions such as Asia Pacific and Latin America, these regions are likely to exhibit significant growth opportunities.
In conclusion, the global transthyretin stabilizer market is expected to grow as more effective treatments are developed and approved for ATTR. The market is driven by the increasing prevalence of the disease and the need for therapies that can stabilize the TTR protein and slow disease progression.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer.
Report Scope
The Transthyretin Stabilizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transthyretin Stabilizer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Stabilizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.
Segment by Type
Diflunisal
Tafamidis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transthyretin Stabilizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.A transthyretin (TTR) stabilizer is a type of medication or compound that is used in the treatment of transthyretin amyloidosis (ATTR), a rare genetic disorder characterized by the deposition of abnormal TTR protein in various organs and tissues.
TTR stabilizers work by binding to and stabilizing the TTR protein, preventing it from misfolding and forming amyloid fibrils. By stabilizing the TTR protein, these medications aim to slow down or halt the progression of the disease and potentially alleviate symptoms.
The global Transthyretin Stabilizer market was valued at US$ 1480 million in 2023 and is anticipated to reach US$ 2372.8 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global transthyretin stabilizer market refers to the market for medications and compounds used in the treatment of transthyretin amyloidosis (ATTR) by stabilizing the transthyretin (TTR) protein. This market encompasses various drugs that have been developed or under development as TTR stabilizers.
Currently, there are several TTR stabilizers that have gained regulatory approval or are in advanced stages of clinical development. The market is primarily driven by the rising prevalence of ATTR, increasing awareness of the disease, and the need for effective treatment options.
One of the key drugs in the market is tafamidis, which is approved in several countries for the treatment of ATTR polyneuropathy. Tafamidis has shown to stabilize TTR and slow disease progression in clinical trials. Other drugs such as diflunisal, AG10, inotersen, and patisiran are also being investigated and have shown promising results in clinical studies.
The market is expected to witness significant growth as more research is conducted on the development of TTR stabilizers and as regulatory approvals are obtained for these drugs in different regions. Additionally, the ongoing efforts to increase disease awareness among healthcare professionals and patients are likely to contribute to the market growth.
Key players in the global transthyretin stabilizer market include pharmaceutical companies such as Pfizer Inc., Alnylam Pharmaceuticals, Inc., Eidos Therapeutics, and Ionis Pharmaceuticals Inc., among others. These companies invest in research and development activities to develop new TTR stabilizers and expand their product portfolios.
Geographically, North America and Europe are leading regions in the market, primarily due to the higher prevalence of ATTR and the presence of established healthcare infrastructure. However, as awareness and diagnosis of ATTR improve in other regions such as Asia Pacific and Latin America, these regions are likely to exhibit significant growth opportunities.
In conclusion, the global transthyretin stabilizer market is expected to grow as more effective treatments are developed and approved for ATTR. The market is driven by the increasing prevalence of the disease and the need for therapies that can stabilize the TTR protein and slow disease progression.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer.
Report Scope
The Transthyretin Stabilizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transthyretin Stabilizer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin Stabilizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.
Segment by Type
Diflunisal
Tafamidis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transthyretin Stabilizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transthyretin Stabilizer Market Overview
1.1 Product Overview and Scope of Transthyretin Stabilizer
1.2 Transthyretin Stabilizer Segment by Type
1.2.1 Global Transthyretin Stabilizer Market Value Comparison by Type (2024-2030)
1.2.2 Diflunisal
1.2.3 Tafamidis
1.2.4 Others
1.3 Transthyretin Stabilizer Segment by Application
1.3.1 Global Transthyretin Stabilizer Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.3.6 Others
1.4 Global Transthyretin Stabilizer Market Size Estimates and Forecasts
1.4.1 Global Transthyretin Stabilizer Revenue 2019-2030
1.4.2 Global Transthyretin Stabilizer Sales 2019-2030
1.4.3 Global Transthyretin Stabilizer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transthyretin Stabilizer Market Competition by Manufacturers
2.1 Global Transthyretin Stabilizer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transthyretin Stabilizer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transthyretin Stabilizer Average Price by Manufacturers (2019-2024)
2.4 Global Transthyretin Stabilizer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transthyretin Stabilizer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transthyretin Stabilizer, Product Type & Application
2.7 Transthyretin Stabilizer Market Competitive Situation and Trends
2.7.1 Transthyretin Stabilizer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transthyretin Stabilizer Players Market Share by Revenue
2.7.3 Global Transthyretin Stabilizer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transthyretin Stabilizer Retrospective Market Scenario by Region
3.1 Global Transthyretin Stabilizer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transthyretin Stabilizer Global Transthyretin Stabilizer Sales by Region: 2019-2030
3.2.1 Global Transthyretin Stabilizer Sales by Region: 2019-2024
3.2.2 Global Transthyretin Stabilizer Sales by Region: 2025-2030
3.3 Global Transthyretin Stabilizer Global Transthyretin Stabilizer Revenue by Region: 2019-2030
3.3.1 Global Transthyretin Stabilizer Revenue by Region: 2019-2024
3.3.2 Global Transthyretin Stabilizer Revenue by Region: 2025-2030
3.4 North America Transthyretin Stabilizer Market Facts & Figures by Country
3.4.1 North America Transthyretin Stabilizer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transthyretin Stabilizer Sales by Country (2019-2030)
3.4.3 North America Transthyretin Stabilizer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transthyretin Stabilizer Market Facts & Figures by Country
3.5.1 Europe Transthyretin Stabilizer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transthyretin Stabilizer Sales by Country (2019-2030)
3.5.3 Europe Transthyretin Stabilizer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transthyretin Stabilizer Market Facts & Figures by Country
3.6.1 Asia Pacific Transthyretin Stabilizer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transthyretin Stabilizer Sales by Country (2019-2030)
3.6.3 Asia Pacific Transthyretin Stabilizer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transthyretin Stabilizer Market Facts & Figures by Country
3.7.1 Latin America Transthyretin Stabilizer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transthyretin Stabilizer Sales by Country (2019-2030)
3.7.3 Latin America Transthyretin Stabilizer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transthyretin Stabilizer Market Facts & Figures by Country
3.8.1 Middle East and Africa Transthyretin Stabilizer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transthyretin Stabilizer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transthyretin Stabilizer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transthyretin Stabilizer Sales by Type (2019-2030)
4.1.1 Global Transthyretin Stabilizer Sales by Type (2019-2024)
4.1.2 Global Transthyretin Stabilizer Sales by Type (2025-2030)
4.1.3 Global Transthyretin Stabilizer Sales Market Share by Type (2019-2030)
4.2 Global Transthyretin Stabilizer Revenue by Type (2019-2030)
4.2.1 Global Transthyretin Stabilizer Revenue by Type (2019-2024)
4.2.2 Global Transthyretin Stabilizer Revenue by Type (2025-2030)
4.2.3 Global Transthyretin Stabilizer Revenue Market Share by Type (2019-2030)
4.3 Global Transthyretin Stabilizer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transthyretin Stabilizer Sales by Application (2019-2030)
5.1.1 Global Transthyretin Stabilizer Sales by Application (2019-2024)
5.1.2 Global Transthyretin Stabilizer Sales by Application (2025-2030)
5.1.3 Global Transthyretin Stabilizer Sales Market Share by Application (2019-2030)
5.2 Global Transthyretin Stabilizer Revenue by Application (2019-2030)
5.2.1 Global Transthyretin Stabilizer Revenue by Application (2019-2024)
5.2.2 Global Transthyretin Stabilizer Revenue by Application (2025-2030)
5.2.3 Global Transthyretin Stabilizer Revenue Market Share by Application (2019-2030)
5.3 Global Transthyretin Stabilizer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Transthyretin Stabilizer Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Merck & Co.
6.2.1 Merck & Co. Corporation Information
6.2.2 Merck & Co. Description and Business Overview
6.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co. Transthyretin Stabilizer Product Portfolio
6.2.5 Merck & Co. Recent Developments/Updates
6.3 AstraZeneca Plc.
6.3.1 AstraZeneca Plc. Corporation Information
6.3.2 AstraZeneca Plc. Description and Business Overview
6.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Plc. Transthyretin Stabilizer Product Portfolio
6.3.5 AstraZeneca Plc. Recent Developments/Updates
6.4 GlaxoSmithKline Plc.
6.4.1 GlaxoSmithKline Plc. Corporation Information
6.4.2 GlaxoSmithKline Plc. Description and Business Overview
6.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolio
6.4.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.5 Corino Therapeutics Inc.
6.5.1 Corino Therapeutics Inc. Corporation Information
6.5.2 Corino Therapeutics Inc. Description and Business Overview
6.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolio
6.5.5 Corino Therapeutics Inc. Recent Developments/Updates
6.6 Alnylam Pharmaceuticals
6.6.1 Alnylam Pharmaceuticals Corporation Information
6.6.2 Alnylam Pharmaceuticals Description and Business Overview
6.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolio
6.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.7 Bellus Health Inc.
6.6.1 Bellus Health Inc. Corporation Information
6.6.2 Bellus Health Inc. Description and Business Overview
6.6.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bellus Health Inc. Transthyretin Stabilizer Product Portfolio
6.7.5 Bellus Health Inc. Recent Developments/Updates
6.8 Ionis Pharmaceuticals, Inc.
6.8.1 Ionis Pharmaceuticals, Inc. Corporation Information
6.8.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolio
6.8.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
6.9 Proclara Bioscience
6.9.1 Proclara Bioscience Corporation Information
6.9.2 Proclara Bioscience Description and Business Overview
6.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Proclara Bioscience Transthyretin Stabilizer Product Portfolio
6.9.5 Proclara Bioscience Recent Developments/Updates
6.10 Arturus Therapeutics
6.10.1 Arturus Therapeutics Corporation Information
6.10.2 Arturus Therapeutics Description and Business Overview
6.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arturus Therapeutics Transthyretin Stabilizer Product Portfolio
6.10.5 Arturus Therapeutics Recent Developments/Updates
6.11 Prothena Corporation Plc.
6.11.1 Prothena Corporation Plc. Corporation Information
6.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Description and Business Overview
6.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolio
6.11.5 Prothena Corporation Plc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transthyretin Stabilizer Industry Chain Analysis
7.2 Transthyretin Stabilizer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transthyretin Stabilizer Production Mode & Process
7.4 Transthyretin Stabilizer Sales and Marketing
7.4.1 Transthyretin Stabilizer Sales Channels
7.4.2 Transthyretin Stabilizer Distributors
7.5 Transthyretin Stabilizer Customers
8 Transthyretin Stabilizer Market Dynamics
8.1 Transthyretin Stabilizer Industry Trends
8.2 Transthyretin Stabilizer Market Drivers
8.3 Transthyretin Stabilizer Market Challenges
8.4 Transthyretin Stabilizer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Transthyretin Stabilizer Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Transthyretin Stabilizer Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Transthyretin Stabilizer Market Competitive Situation by Manufacturers in 2023
Table 4. Global Transthyretin Stabilizer Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Transthyretin Stabilizer Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Transthyretin Stabilizer Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Transthyretin Stabilizer Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Transthyretin Stabilizer Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Transthyretin Stabilizer, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Transthyretin Stabilizer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transthyretin Stabilizer, Product Type & Application
Table 12. Global Key Manufacturers of Transthyretin Stabilizer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transthyretin Stabilizer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Stabilizer as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transthyretin Stabilizer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Transthyretin Stabilizer Sales by Region (2019-2024) & (K Units)
Table 18. Global Transthyretin Stabilizer Sales Market Share by Region (2019-2024)
Table 19. Global Transthyretin Stabilizer Sales by Region (2025-2030) & (K Units)
Table 20. Global Transthyretin Stabilizer Sales Market Share by Region (2025-2030)
Table 21. Global Transthyretin Stabilizer Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Transthyretin Stabilizer Revenue Market Share by Region (2019-2024)
Table 23. Global Transthyretin Stabilizer Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Transthyretin Stabilizer Revenue Market Share by Region (2025-2030)
Table 25. North America Transthyretin Stabilizer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Transthyretin Stabilizer Sales by Country (2019-2024) & (K Units)
Table 27. North America Transthyretin Stabilizer Sales by Country (2025-2030) & (K Units)
Table 28. North America Transthyretin Stabilizer Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Transthyretin Stabilizer Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Transthyretin Stabilizer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Transthyretin Stabilizer Sales by Country (2019-2024) & (K Units)
Table 32. Europe Transthyretin Stabilizer Sales by Country (2025-2030) & (K Units)
Table 33. Europe Transthyretin Stabilizer Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Transthyretin Stabilizer Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Transthyretin Stabilizer Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Transthyretin Stabilizer Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Transthyretin Stabilizer Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Transthyretin Stabilizer Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Transthyretin Stabilizer Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Transthyretin Stabilizer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Transthyretin Stabilizer Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Transthyretin Stabilizer Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Transthyretin Stabilizer Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Transthyretin Stabilizer Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Transthyretin Stabilizer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Transthyretin Stabilizer Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Transthyretin Stabilizer Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Transthyretin Stabilizer Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Transthyretin Stabilizer Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Transthyretin Stabilizer Sales (K Units) by Type (2019-2024)
Table 51. Global Transthyretin Stabilizer Sales (K Units) by Type (2025-2030)
Table 52. Global Transthyretin Stabilizer Sales Market Share by Type (2019-2024)
Table 53. Global Transthyretin Stabilizer Sales Market Share by Type (2025-2030)
Table 54. Global Transthyretin Stabilizer Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Transthyretin Stabilizer Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Transthyretin Stabilizer Revenue Market Share by Type (2019-2024)
Table 57. Global Transthyretin Stabilizer Revenue Market Share by Type (2025-2030)
Table 58. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2019-2024)
Table 59. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2025-2030)
Table 60. Global Transthyretin Stabilizer Sales (K Units) by Application (2019-2024)
Table 61. Global Transthyretin Stabilizer Sales (K Units) by Application (2025-2030)
Table 62. Global Transthyretin Stabilizer Sales Market Share by Application (2019-2024)
Table 63. Global Transthyretin Stabilizer Sales Market Share by Application (2025-2030)
Table 64. Global Transthyretin Stabilizer Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Transthyretin Stabilizer Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Transthyretin Stabilizer Revenue Market Share by Application (2019-2024)
Table 67. Global Transthyretin Stabilizer Revenue Market Share by Application (2025-2030)
Table 68. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2019-2024)
Table 69. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Inc. Corporation Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Inc. Transthyretin Stabilizer Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co. Transthyretin Stabilizer Product
Table 79. Merck & Co. Recent Developments/Updates
Table 80. AstraZeneca Plc. Corporation Information
Table 81. AstraZeneca Plc. Description and Business Overview
Table 82. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. AstraZeneca Plc. Transthyretin Stabilizer Product
Table 84. AstraZeneca Plc. Recent Developments/Updates
Table 85. GlaxoSmithKline Plc. Corporation Information
Table 86. GlaxoSmithKline Plc. Description and Business Overview
Table 87. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Plc. Transthyretin Stabilizer Product
Table 89. GlaxoSmithKline Plc. Recent Developments/Updates
Table 90. Corino Therapeutics Inc. Corporation Information
Table 91. Corino Therapeutics Inc. Description and Business Overview
Table 92. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Corino Therapeutics Inc. Transthyretin Stabilizer Product
Table 94. Corino Therapeutics Inc. Recent Developments/Updates
Table 95. Alnylam Pharmaceuticals Corporation Information
Table 96. Alnylam Pharmaceuticals Description and Business Overview
Table 97. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Alnylam Pharmaceuticals Transthyretin Stabilizer Product
Table 99. Alnylam Pharmaceuticals Recent Developments/Updates
Table 100. Bellus Health Inc. Corporation Information
Table 101. Bellus Health Inc. Description and Business Overview
Table 102. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bellus Health Inc. Transthyretin Stabilizer Product
Table 104. Bellus Health Inc. Recent Developments/Updates
Table 105. Ionis Pharmaceuticals, Inc. Corporation Information
Table 106. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 107. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product
Table 109. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
Table 110. Proclara Bioscience Corporation Information
Table 111. Proclara Bioscience Description and Business Overview
Table 112. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Proclara Bioscience Transthyretin Stabilizer Product
Table 114. Proclara Bioscience Recent Developments/Updates
Table 115. Arturus Therapeutics Corporation Information
Table 116. Arturus Therapeutics Description and Business Overview
Table 117. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Arturus Therapeutics Transthyretin Stabilizer Product
Table 119. Arturus Therapeutics Recent Developments/Updates
Table 120. Prothena Corporation Plc. Corporation Information
Table 121. Prothena Corporation Plc. Description and Business Overview
Table 122. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Prothena Corporation Plc. Transthyretin Stabilizer Product
Table 124. Prothena Corporation Plc. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Transthyretin Stabilizer Distributors List
Table 128. Transthyretin Stabilizer Customers List
Table 129. Transthyretin Stabilizer Market Trends
Table 130. Transthyretin Stabilizer Market Drivers
Table 131. Transthyretin Stabilizer Market Challenges
Table 132. Transthyretin Stabilizer Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transthyretin Stabilizer
Figure 2. Global Transthyretin Stabilizer Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Transthyretin Stabilizer Market Share by Type in 2023 & 2030
Figure 4. Diflunisal Product Picture
Figure 5. Tafamidis Product Picture
Figure 6. Others Product Picture
Figure 7. Global Transthyretin Stabilizer Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Transthyretin Stabilizer Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Drug Stores
Figure 12. Online Pharmacies
Figure 13. Others
Figure 14. Global Transthyretin Stabilizer Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Transthyretin Stabilizer Market Size (2019-2030) & (US$ Million)
Figure 16. Global Transthyretin Stabilizer Sales (2019-2030) & (K Units)
Figure 17. Global Transthyretin Stabilizer Average Price (US$/Unit) & (2019-2030)
Figure 18. Transthyretin Stabilizer Report Years Considered
Figure 19. Transthyretin Stabilizer Sales Share by Manufacturers in 2023
Figure 20. Global Transthyretin Stabilizer Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Transthyretin Stabilizer Players: Market Share by Revenue in 2023
Figure 22. Transthyretin Stabilizer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Transthyretin Stabilizer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Transthyretin Stabilizer Sales Market Share by Country (2019-2030)
Figure 25. North America Transthyretin Stabilizer Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Transthyretin Stabilizer Sales Market Share by Country (2019-2030)
Figure 29. Europe Transthyretin Stabilizer Revenue Market Share by Country (2019-2030)
Figure 30. Germany Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Transthyretin Stabilizer Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Transthyretin Stabilizer Revenue Market Share by Region (2019-2030)
Figure 37. China Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Transthyretin Stabilizer Sales Market Share by Country (2019-2030)
Figure 48. Latin America Transthyretin Stabilizer Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Transthyretin Stabilizer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Transthyretin Stabilizer by Type (2019-2030)
Figure 58. Global Revenue Market Share of Transthyretin Stabilizer by Type (2019-2030)
Figure 59. Global Transthyretin Stabilizer Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Transthyretin Stabilizer by Application (2019-2030)
Figure 61. Global Revenue Market Share of Transthyretin Stabilizer by Application (2019-2030)
Figure 62. Global Transthyretin Stabilizer Price (US$/Unit) by Application (2019-2030)
Figure 63. Transthyretin Stabilizer Value Chain
Figure 64. Transthyretin Stabilizer Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
